APA (7th ed.) Citation

Betge, J., Chi-Kern, J., Schulte, N., Belle, S., Gutting, T., Burgermeister, E., . . . Härtel, N. (2018). A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). BioMed Central : Springer. https://doi.org/10.1186/s12885-018-4665-2

Chicago Style (17th ed.) Citation

Betge, Johannes, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Matthias Ebert, and Nicolai Härtel. A Multicenter Phase 4 Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/− Nab-paclitaxel in Elderly Pancreatic Cancer Patients (GrantPax). London Berlin Heidelberg: BioMed Central : Springer, 2018. https://doi.org/10.1186/s12885-018-4665-2.

MLA (9th ed.) Citation

Betge, Johannes, et al. A Multicenter Phase 4 Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/− Nab-paclitaxel in Elderly Pancreatic Cancer Patients (GrantPax). BioMed Central : Springer, 2018. https://doi.org/10.1186/s12885-018-4665-2.